4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-25-000201
EVP, Chief Scientific Officer sold 52 shares at $424.69 ($22,084)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ALTSHULER DAVID · EVP, Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-05-15 | Sale : show line 1 in the form 10b5-1 | −52 | $424.69 | $22,084 | 23,281 | D |
| Open-market sales · 52 sh · avg $424.69 · $22,084 | ||||||
Loading xslF345X05/wk-form4_1747688856.xml…